We serve Furan-2-yl(piperazin-1-yl)methanone hydrochloride CAS:60548-09-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Furan-2-yl(piperazin-1-yl)methanone hydrochloride
CAS.NO: 60548-09-6
Synonyms:
furan-2-yl(piperazin-1-yl)methanone,hydrochloride
Molecular Formula: C9H13ClN2O2
Molecular Weight: 216.66500
Physical and Chemical Properties:
Density: 0.694 g / mL at 25 ° C (lit.)
Boiling point: 40-41 ° C (lit.)
Melting point: −148 ° C (lit.)
Flash point: 10 ° F
Refractive index: n20 / D 1.419 (lit.)
Specification:
Appearance:White to off-white solid
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Prazosin hydrochloride CAS:19237-84-4
Contact us for information like Furan-2-yl(piperazin-1-yl)methanone hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,furan-2-yl(piperazin-1-yl)methanone,hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Furan-2-yl(piperazin-1-yl)methanone hydrochloride Use and application,furan-2-yl(piperazin-1-yl)methanone,hydrochloride technical grade,usp/ep/jp grade.
Related News: High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.2-Fluoro-4-iodo-5-picoline manufacturer Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.3,4-Dimethoxyaniline supplier Delta said it will suspend flights between the United States and China starting on Sunday until at least April 30, according to a press release.N-BOC-4,4-difluoro-L-proline vendor The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near
